Overview
AIRA is building Colligo, an enterprise-grade collaborative AI platform for clinical trial design and regulatory document development. It helps biopharma teams and CROs shorten protocol timelines by ~40%, reduce costs by $450K-$1.2M per trial, and prevent costly rework and amendments.
Inside AIRA, built-in AI agents spanning clinical, regulatory, biostatistical, and medical writing expertise augment clinical development teams. They continuously track the evolving study context and develop it with your team, surfacing trial design suggestions and optimization opportunities, flagging risks, and drafting regulatory documents.